Agios Pharmaceuticals
AGIO
AGIO
208 hedge funds and large institutions have $4.29B invested in Agios Pharmaceuticals in 2018 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 71 increasing their positions, 74 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
4% less funds holding
Funds holding: 217 → 208 (-9)
6% less capital invested
Capital invested by funds: $4.54B → $4.29B (-$253M)
23% less first-time investments, than exits
New positions opened: 23 | Existing positions closed: 30
Holders
208
Holding in Top 10
4
Calls
$25.1M
Puts
$19.8M
Top Buyers
| 1 | +$71.5M | |
| 2 | +$33.2M | |
| 3 | +$23.7M | |
| 4 |
Capital International Investors
Los Angeles,
California
|
+$22.5M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$17M |
Top Sellers
| 1 | -$54.8M | |
| 2 | -$51.8M | |
| 3 | -$25.6M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$9.33M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$9.01M |